Clinical Scorecard: New World Medical Secures EU Certification for Three Glaucoma Devices
At a Glance
| Category | Detail |
|---|---|
| Condition | Glaucoma requiring surgical management to reduce intraocular pressure |
| Key Mechanisms | The Ahmed Glaucoma Valve and Ahmed ClearPath direct aqueous humor away from the anterior chamber; KDB GLIDE is used for excisional goniotomy to improve aqueous outflow through the trabecular meshwork. |
| Target Population | Patients with glaucoma for whom surgical intervention is considered; the article specifically describes the Ahmed ClearPath ST as intended for refractory glaucoma. |
| Care Setting | European glaucoma surgical care; the three devices have EU MDR certification for continued supply in Europe. |
Key Highlights
- New World Medical received EU MDR certification for the Ahmed Glaucoma Valve, Ahmed ClearPath, and KDB GLIDE.
- The devices were previously available in European markets under the Medical Device Directive.
- The Ahmed Glaucoma Valve and Ahmed ClearPath are drainage implants; KDB GLIDE is used to perform excisional goniotomy.
- The company is pursuing EU MDR certification for the Ahmed ClearPath ST, which is not yet EU MDR certified.
- The company says the Ahmed ClearPath ST is approved in more than 20 countries and intended for refractory glaucoma.
Guideline-Based Recommendations
Diagnosis
Management
- The article describes the certified devices as surgical options for glaucoma management; it does not provide treatment-selection recommendations.
Monitoring & Follow-up
Risks
- The article does not report clinical risks or adverse-event data for the devices.
Patient & Prescribing Data
The devices are described for patients requiring surgical management of glaucoma; the Ahmed ClearPath ST is intended for refractory glaucoma.
The Ahmed Glaucoma Valve and Ahmed ClearPath are drainage implant options, while KDB GLIDE is used for excisional goniotomy. The article provides no comparative efficacy, dosing, or patient-selection data.
Clinical Best Practices
- The article reports EU MDR certification status but does not provide clinical practice recommendations.
- The Ahmed ClearPath ST has not yet received EU MDR certification, according to the article.
Related Resources & Content
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
